title: Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells.
abstract: Within the nuclear receptor family, Nur77 (also known as NGFI-B) distinguishes itself by its ability to bind a target sequence (the NBRE) as a monomer and by its role in T-cell receptor (TCR)-induced apoptosis in T cells. We now report on a novel mechanism of Nur77 action that is mediated by homodimers. These dimers bind a Nur77 response element (NurRE), which has been identified as a target of CRH-induced Nur77 in the pro-opiomelanocortin (POMC) gene promoter. Both halves of the palindromic NurRE are required for responsiveness to physiological signals, like CRH in pituitary-derived AtT-20 cells. Similarly, in T-cell hybridomas, TCR activation induced NurRE but not NBRE reporters. The in vivo signaling function of Nur77 thus appears to be mediated by dimers acting on a palindromic response element of unusual spacing between its half-sites. This mechanism may represent the biologically relevant paradigm of action for this subfamily of orphan nuclear receptors.
authors.affiliation: Laboratoire de Génétique Moléculaire, Institut de Recherches Cliniques de Montréal, Québec, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Philips
authors.forename: S
authors.initials: S
authors.lastname: Lesage
authors.forename: R
authors.initials: R
authors.lastname: Gingras
authors.forename: M H
authors.initials: MH
authors.lastname: Maira
authors.forename: Y
authors.initials: Y
authors.lastname: Gauthier
authors.forename: P
authors.initials: P
authors.lastname: Hugo
authors.forename: J
authors.initials: J
authors.lastname: Drouin
mesh_terms: D000818:Animals; D005576:Colforsin / Q000494:pharmacology; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology; D000242:Cyclic AMP / Q000502:physiology; D004247:DNA / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D019281:Dimerization; D005786:Gene Expression Regulation / Q000502:physiology; D006825:Hybridomas; D051379:Mice; D009154:Mutation; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1; D010903:Pituitary Gland, Anterior / Q000166:cytology / Q000502:physiology*; D011333:Pro-Opiomelanocortin / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000235:genetics; D011948:Receptors, Antigen, T-Cell / Q000502:physiology; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics / Q000378:metabolism*; D011987:Receptors, Steroid; D015398:Signal Transduction / Q000502:physiology*; D013601:T-Lymphocytes / Q000166:cytology / Q000502:physiology*; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*; D014407:Tumor Cells, Cultured
chemical_list: D004268:DNA-Binding Proteins; C539818:Nr4a1 protein, mouse; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1; D011948:Receptors, Antigen, T-Cell; D018160:Receptors, Cytoplasmic and Nuclear; D011987:Receptors, Steroid; D014157:Transcription Factors; D005576:Colforsin; D011333:Pro-Opiomelanocortin; D004247:DNA; D003346:Corticotropin-Releasing Hormone; D000242:Cyclic AMP